Unusual electrocardiographic changes with propranolol and diltiazem overdosage: a case report

Salim Satar1, Ayca Acikalin, Onur Akpinar

  • 1Emergency Department, Faculty of Medicine, Cukurova University, Adana, Turkey. ssatar@mail.cu.edu.tr

Insights

Beta-blockers and calcium channel blockers treat cardiovascular conditions. This case study details a rare suicidal overdose of propranolol and diltiazem, highlighting unusual ECG changes and the need for careful patient monitoring.

Area of Science:

  • Cardiology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Beta-adrenoreceptor-blocking drugs (beta-blockers) and calcium antagonists (calcium channel blockers) are widely used for cardiovascular conditions like angina, arrhythmias, and hypertension.
  • Combination therapy with drugs like propranolol and diltiazem requires careful patient selection and monitoring due to potential adverse cardiovascular effects.

Observation:

  • This article presents a unique case of a suicidal drug overdose involving both propranolol and diltiazem.
  • The overdose resulted in distinct and unusual electrocardiographic (ECG) changes.

Findings:

  • The case highlights the complex cardiovascular effects that can arise from an overdose of combined beta-blocker and calcium channel blocker medications.
  • Specific, atypical ECG findings were observed, underscoring the potential for severe toxicity.

Implications:

  • This case emphasizes the critical importance of meticulous patient selection and close observation when prescribing combination cardiovascular therapies.
  • Understanding the specific toxicological profiles and ECG manifestations of combined drug overdoses is crucial for emergency medical management.
  • Further research into the electrophysiological consequences of combined beta-blocker and calcium channel blocker toxicity may be warranted.

Related Concept Videos

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...